Xalatan goes generic in latest Japanese price listing
This article was originally published in Scrip
Executive Summary
The most recent reimbursement price listing of generic drugs in Japan has seen several branded products opened up to such competition for the first time, including Pfizer's Xalatan (latanoprost).